Mangoceuticals Inc.

NASDAQ: MGRX · Real-Time Price · USD
1.63
0.05 (3.16%)
At close: Aug 15, 2025, 9:37 AM

Mangoceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
615.87K 731.49K 8.94K n/a
Cost of Revenue
235.91K 299.99K 4.09K n/a
Gross Profit
379.96K 431.5K 4.85K n/a
Operating Income
-7.97M -9.22M -1.99M -17.52K
Interest Income
n/a n/a n/a n/a
Pretax Income
-8.71M -9.21M -2M -70.8K
Net Income
-8.71M -9.21M -2M -17.7K
Selling & General & Admin
7.9M 8.55M 2M 17.52K
Research & Development
n/a n/a n/a n/a
Other Expenses
453.75K 1.1M n/a n/a
Operating Expenses
8.35M 9.65M 2M 17.52K
Interest Expense
13.7K n/a 6.47K 181.00
Selling & Marketing Expenses
1.48M 2.1M 352.86K n/a
Cost & Expenses
8.59M 9.95M 2M 17.52K
Income Tax Expense
n/a n/a n/a -70.08K
Shares Outstanding (Basic)
1.98M 1.07M 1.02M 997.67K
Shares Outstanding (Diluted)
1.98M 1.07M 1.02M 997.67K
EPS (Basic)
-4.84 -8.58 -1.96 -0.02
EPS (Diluted)
-4.84 -8.58 -1.96 -0.02
EBITDA
-7.96M -9.19M -1.99M 52.56K
EBIT
-8.69M -9.21M -1.99M -17.52K
Depreciation & Amortization
721.53K 24.89K 3.86K 70.08K